Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team...

Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023...

FILAMENT HEALTH ANNOUNCES SECOND PSILOCYBIN SUPPLY AGREEMENT WITH THE CENTRE FOR...

Israel-Based Clearmind Medicine to Present at The OurCrowd Global Investor Summit...

Silo Pharma Announces Filing of Patent for Treatment of Alzheimer’s

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Psychedelics Weekly – AIMS vs. the DEA: An Update on the...

Establishing the Psychedelic Research Center Consortium​

Key Psychedelic Research Themes in 2022

PT388 – Vital Psychedelic Conversations

Load more